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Members of the fibroblast growth factor (FGF) family of peptide growth factors are widely expressed in the germ layer
derivatives during gastrulation and early organogenesis of the mouse. We have investigated the effect of administering
recombinant FGF-4 in the late-primitive streak stage embryo to test if the patterning of the body plan may be influenced by
this growth factor. Shortly after FGF treatment the embryonic tissues up-regulated the expression of Brachyury and the
TK signaling regulator Spry2, suggesting that FGF signaling was activated as an immediate response to exogenous FGF.
oncomitantly, Hesx1 expression was suppressed in the prospective anterior region of the embryo. After 24 h of in vitro
development, embryos displayed a dosage-related suppression of forebrain morphogenesis, disruption of the midbrain–
hindbrain partition, and inhibition of the differentiation of the embryonic mesoderm. Overall, development of the
anterior–posterior axis in the late gastrula is sensitive to the delivery of exogenous FGF-4. The early response associated
with the expression of Spry2 suggests that the later phenotype observed could be primarily related to an inhibition of the
FGF signaling pathway. © 2000 Academic Press
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SINTRODUCTION
The molecular mechanism underpinning the develop-
ment of correct anterior–posterior neural characteristics
has been the subject of much fascination. How this region-
alization of the neural axis is brought about remains largely
undefined although several candidate posteriorizing factors
have been identified including the fibroblast growth factor
(FGF) family of peptide growth factors (Sasai and De
Robertis, 1997). Studies of this expanding family of mol-
ecules have revealed a complicated ligand–receptor signal-
ing network involving a hierarchy of interactions between
multiple functional isoforms with secreted, membrane-
bound, and intracellular activity (Johnson and Williams,
1993; Minowada et al., 1999, and references therein). A
number of genes activated by FGF signaling, such as the
T-box family of transcription factors, caudal-related genes
(Xcad3), and a novel TGFb member (derriere) (Smith, 1999;
1 To whom correspondence should be addressed. Fax: (02) 9687
a2120. E-mail: bdavidson@cmri.usyd.edu.au.
0012-1606/00 $35.00
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All rights of reproduction in any form reserved.ownall et al., 1998; Sun, B. I., et al., 1999), are involved in
egulating posterior embryonic development. Further com-
lexity is added when negative regulators, such as the
prouty genes in Drosophila, chick, and mouse, are in-
olved in the modulation of FGF signaling (Hacohen et al.,
998; Casci et al., 1999; Tefft et al., 1999; Kramer et al.,
999; Reich et al., 1999; Minowada et al., 1999).
The role of FGFs during gastrulation remains obscure and
ften contradictory due to the reiterative requirement for
any family members during this period and the inherent
ifferences in the response of the experimental system. In
enopus gastrula, FGFs have been shown to have
esodermal- and neural-inducing activity while studies of the
ominant negative FGFR have revealed a requirement in the
evelopment of posterior structures (reviewed by Doniach,
995). Recently a separable anterior–posterior patterning
echanism has been revealed by studies in Keller explants
hich have demonstrated a requirement for FGFR signaling in
he determination of posterior neural identity (Holowacz and
okol, 1999). In zebrafish, the formation of the trunk and tail
re regulated by FGF activity and T-box family members
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42 Davidson et al.while dominant-negative FGFR studies suggest an indirect
involvement of FGF activity in restricting the expression of
anterior neural identity (Griffin et al., 1995, 1998; Koshida et
l., 1998). Furthermore, anterior development can also be
uppressed by exogenous FGF activity in both zebrafish and
enopus (Griffin et al., 1995, 1998; Holowacz and Sokol, 1999
nd references therein). In the chick embryo, varying effects
ave been reported depending on the dosage, the location, and
he stage of embryonic development when exogenous FGF is
opically applied (reviewed by Kessel and Pera, 1998). These
nclude the induction of anterior and/or posterior neural
issue with or without the formation of mesoderm and, at
igh doses, the suppression of anterior development (Hen-
ique et al., 1997; Alvarez et al., 1998; Storey et al., 1998).
In the mouse, the effects of FGF signaling have largely
een investigated by functionally inactivating various fam-
ly members. Although several null mutants have not
evealed a requirement during gastrulation (Feldman et al.,
995; Mansour et al., 1993; He`bert et al., 1994), the condi-
tional mutagenesis of Fgf8 has been successful in determin-
ing a role for this family member in the migration of the
embryonic mesoderm, formation of the midbrain–
hindbrain boundary, and branchial arch development (Mey-
ers et al., 1998; Sun, X., et al., 1999; Trumpp et al., 1999).
Furthermore, a requirement for FGF signaling in the correct
specification and the migration of the mesoderm during
gastrulation and early organogenesis has been inferred from
the phenotypes of FGFR1 null mutants and chimeras
(Yamaguchi et al., 1994; Deng et al., 1994; Ciruna et al.,
997; Deng et al., 1997).
In this study the role of FGF signaling during mouse
evelopment was investigated by examining the effect of
elivering exogenous recombinant FGF-4 to the late gastrula
mbryo. The early response of the embryonic tissues to FGF-4
as assessed by assaying the activity of genes that are ex-
ressed in a regionalized manner, such as T, Hesx1, Otx2, and
oxb1. After a longer period of culture the effect of ectopic
GF-4 on the developing embryo was determined by assaying
ene expression in the forebrain, midbrain, and hindbrain
egions and the mesoderm. Recently, Minowada et al. (1999)
ave shown that Sprouty gene activity, which apparently
epresses FGF signaling, is up-regulated in mouse and chick
mbryos shortly after the application of exogenous FGFs. In
he present study, we found that Spry2 expression was up-
regulated shortly after FGF-4 bead implantation, and its activ-
ity remained elevated after a prolonged period of in vitro
development. We propose that the phenotypic consequences
of FGF treatment on embryonic development may be due
more to a widespread inhibition of FGF signaling activity that
accompanies an initial activation by exogenous FGF-4.
MATERIALS AND METHODS
Preparation of FGF-4- and FGF-8b-Coated Beads
FGF protein was delivered to the mouse embryo in vitro by the
implantation of beads that carry the protein on the heparin-coated
Copyright © 2000 by Academic Press. All rightsurface. Acrylic beads (Sigma) were first rinsed several times in 500
ml of PBS. Approximately 40–50 beads were added to a 5-ml aliquot
f recombinant human FGF-4 (Sigma) or recombinant mouse
GF-8b (R&D Systems) solutions diluted in PBS at concentrations
.0, 0.2, or 0.1 mg/ml. FGF incubation of the beads was done in
icrodrops, overlaid with light paraffin oil at 4°C for at least 24 h
rior to use. The effective concentration of FGF-4 in each soaking
olution was determined by ELISA with a goat polyclonal anti-
GF-4 antibody (Santa Cruz Biotechnology Inc.). The ELISA deter-
ination showed that approximately 0.3, 0.07, and 0.03 mg/ml
ffective FGF-4 concentration were found in the three working
olutions after the addition of beads. Control beads were incubated
n either PBS or BSA (1.0 mg/ml) solutions. Growth-factor-loaded
eads were used for up to 3 weeks following the initial preparation.
Embryo Collection, Staging, and Bead
Implantation
ARC/s mouse embryos ranging from the early (allantoic) bud to
early head fold stages of development (Downs and Davis, 1993)
were selected from 7.5 dpc litters. The majority of experiments
were performed on embryos with no overt indication of neural
plate development. To place the bead in the anterior region of the
embryo an incision was made at a point midway between the distal
tip and the embryonic–extraembryonic junction on the anterior
side. The bead was inserted into the incision using a Leica
micromanipulator and was positioned so that it was partially
lodged against the interior tissue layers on the anterior side.
Manipulated embryos were cultured in medium containing 75%
rat serum in Dulbecco’s modified Eagle’s medium (Sturm and Tam,
1993) without rotation for 2 h to allow healing of the wound which
enhanced bead retention. The embryos were cultured in the same
medium in a rotating bottle for a further period of 1–3 or 22 h before
sampling for analysis.
Analysis of FGF Effects on Morphology and Neural
Development
Recombinant FGF-4 and FGF-8b was administered to embryos
that ranged from early bud to early head fold stages of embryonic
development. From these experiments, we determined that the
gastrula embryo was most responsive to the growth factor when it
was delivered prior to the initiation of neurulation. FGF-4 was
more potent than FGF-8b at all stages examined (data not shown).
Further experiments were therefore conducted on the early bud
embryo and using FGF-4 only. Embryos implanted with FGF-4 or
control beads were removed from culture and examined for mor-
phological effects prior to fixation in 4% paraformaldehyde (PFA) at
4°C. Embryos were then processed for in situ hybridization accord-
ng to the protocol of Wilkinson and Nieto (1993) with minor
odifications. Digoxigenin-11–UTP- (Boehringer Mannheim) la-
eled riboprobes were synthesized using the Ampliscribe kit (Epi-
entre Technologies). Overnight hybridizations used SDS, 53 SSC,
nd generally 0.2 mg/ml of probe. No RNase treatment was per-
formed following hybridization while high-stringency posthybrid-
ization washes were carried out at 70°C without the use of
formamide. Following in situ hybridization, embryos were exam-
ined and categorized on the basis of the morphology of the head
folds, somites, and neural tube. Embryos selected for histology
were postfixed in 4% PFA, embedded in paraffin wax, and serially
sectioned at 7–8 mm and examined after counterstaining with
nuclear fast red.
s of reproduction in any form reserved.
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43FGF-4 and Anterior DevelopmentTo assess the immediate impact of recombinant FGF-4 on the
developing embryo, the expression of a set of anterior (Otx2, Hesx1)
and posterior (T, Hoxb1) genes was used as early response markers
after 3–5 h of culture. To determine the effect of FGF-4 on FGFR
activation at both 5 and 24 h after bead implantation, the expres-
sion of a negative regulator of FGFR signaling, Spry2 (Minowada et
al., 1999) was also examined. Only the highest dosage of FGF-4 was
used for analyzing the immediate effect of FGF-4 on expression. For
embryos cultured for 24 h a dose–response analysis was undertaken
to determine the threshold effect of FGF activity on morphology.
Genes that are expressed in a regional pattern in the early somite
stage embryo were studied. These included the panneural marker
Sox2 and markers of the forebrain (Hesx1, Six3, and Fgf8), the
fore-/midbrain region (Otx2, En1, Wnt1, and Fgf8), the hindbrain
(Krox20, Hoxb1), and the axial mesoderm and primitive streak (T,
Wnt3a, and Fgf8).
RESULTS
FGF-Treated Embryos Display Dosage-Related
Morphological Effects
A dose-dependent response was observed which ranged
from severely suppressed anterior development and abnor-
mal axial development to essentially normal morphology
(Fig. 1). Several broad morphological criteria were used to
categorize the embryo according to the abnormal pheno-
types. Embryos were scored for the relative size of head
folds, presence of somites, and a visible axis (i.e., a distinct
axial midline and neural tube). Embryos from each treat-
ment group were then put into three classes depending on
the severity of the morphological disruption (Figs. 1B to 1I,
Table 1). The relative proportion of each category correlates
with the dose of FGF-4. The wide range of phenotypes may
be related to subtle differences in embryonic stage or the
amount and activity of growth factor effectively delivered
by a bead.
Anterior and Posterior Gene Expression Is
Disrupted Shortly after FGF Delivery
The expression of T transcript in the treated embryo was
examined at either 3 or 5 h after bead implantation to
determine whether this T-box family member is responsive
to FGF-4. In control embryos T expression is restricted to a
osterior wedge of germ layer tissue, the ingressing epiblast,
nd the newly formed mesoderm of the primitive streak
Figs 2A and 2B). Embryos treated with the highest dose of
GF-4 displayed expanded T expression that encompasses
he epiblast and the mesoderm in the lateral region of the
mbryo (Figs. 2A and 2C).
In view of the expansion of the T expression in the
osterior region of the embryo, the expression of Hesx1 and
tx2 that characterizes the anterior neural tissue was
nalyzed. Complementary to the expanded expression do-
ain of T, Hesx1 expression in the anterior endoderm was
ignificantly suppressed (Figs. 2D–2F). In contrast, Otx2
xpression which marks the presumptive fore- and mid-
Copyright © 2000 by Academic Press. All rightrain regions was not altered (Fig. 2G). Similarly, Hoxb1,
hich is expressed in the posterior epiblast and ingressed
esoderm of the primitive streak, did not show any change
n expression within 5 h of bead placement (Fig. 2H).
Spry2 Expression Is Up-Regulated after FGF
Treatment
The rapid and uniform increase in the posterior expres-
sion of T, which is known to respond to FGF signaling,
suggested that the effect of recombinant FGF-4 may be
widespread in the embryo. Previous studies using either
MAPK activation assays or DIG-labeled FGF have shown
that FGF can diffuse over a considerable distance from
either the bead or the transplanted cells that release the
growth factor (Labonne and Whitman, 1997; Storey et al.,
1998; Christen and Slack, 1999). Studies in Drosophila have
revealed that the Sprouty gene product is a component of a
egative feedback loop regulating FGFR and EGFR pathway
ctivity (reviewed by Placzek and Skaer, 1999). Further-
ore, Sprouty expression can be rapidly induced in re-
sponse to ectopic FGF in the chick and is involved with FGF
signaling in the mouse gastrula, where in the absence of the
Fgf8 activity, no Sprouty expression is detected (Minowada
et al., 1999). We therefore examined the expression of
mouse Spry2 to determine the extent of FGFR activation
ollowing FGF-4 treatment.
Expression of Spry2 is normally restricted to the primi-
ive streak region of the gastrula embryo (Figs. 3A, 3Bi, and
C, see Minowada et al., 1999), a region where several FGF
genes (Fgf3, Fgf4, Fgf5, Fgf8, and Fgf17) as well as Spry4 are
expressed. A marked elevation in Spry2 expression was
observed shortly after FGF-4 delivery (Figs. 3A and 3Bii–iv).
Spry2 expression was widespread in the epiblast of the
embryo (Fig. 3D), a region which is also a site of Fgfr1
expression (Yamaguchi et al., 1992). Of particular interest is
the absence of Spry2 expression in the node and head
process of the embryo and in extraembryonic tissues (Fig.
3Bii–iv).
To determine whether Spry2 expression is sustained after
FGF treatment, embryos were examined at 24 h of culture.
In control embryos, Spry2 was expressed in sites of endog-
enous Fgf activity such as the region where the caudal
midbrain adjoins the rostral hindbrain, the tail bud, and, in
some embryos, the rostral part of the forebrain (Fig. 3E;
Minowada et al., 1999). Spry2 was also expressed in the
posterior paraxial mesoderm and the tail bud (Fig. 3E). In
contrast, FGF-4-treated embryos displayed, besides expres-
sion of Spry2 in the neuroectoderm (Figs. 3F–3H, 3L,and
3M), ectopic expression of Spry2 in the mesendoderm of the
foregut (Fig. 3I) and the midgut (Fig. 3J). In severely affected
embryos, histological examination revealed that paraxial
mesoderm was absent (Fig. 3J) and Spry2 mRNA was found
in the endoderm lying directly underneath the neural tube
(Fig. 3J). The primitive streak of treated embryos was
abnormal in tissue organization and failed to express detect-
able levels of the Spry2 gene (Fig 3K), although expression
s of reproduction in any form reserved.
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44 Davidson et al.FIG. 1. Bead implantation and the morphological effects of FGF-4. (A) An early-bud-stage mouse gastrula embryo held on the posterior
(primitive streak) side by suction to a holding pipette and with a heparin-coated acrylic bead implanted into the anterior region. Bar, 200
mm. (B to E) Lateral, (F and G) dorsal, and (H and I) ventral views of FGF-treated and PBS control embryos. The allantois has been removed.
(B, F) Class I embryos showing poor development of the head folds and a foreshortened body axis, absent somites, and no closure of neural
tube. (C, G) Class II embryos with moderate head fold development and axis elongation, no morphological delineation of fore- and midbrain
segments, and an open neural plate. Only the most anterior somites (that express Meox1, data not shown) are formed but are irregularly
shaped and loosely organized. (D, H) Class III embryos showing normal head fold with well-delineated primary brain parts, a closed neural
tube, and between six and eight pairs of somites. (E, I) Control embryos implanted with PBS-soaked beads. Bar, 150 mm.
FIG. 2. Early response of the embryo to FGF-4 treatment. (A) Expression of Brachyury in PBS control (top row) and FGF-4 treated embryo
(bottom row) 3 h after implantation of beads. Embryos are viewed from the posterior (primitive streak) side. A uniform expansion of T expression
in the posterior lateral region of the embryo was observed after 3 h (n 5 7/7) and also 5 h (n 5 13/13, not shown) when compared to controls (n 5
10 each at 3 and 5 h). (B, C) Transverse sections of (B) PBS control embryo showing expression of T is normally confined to a posterior wedge of
issue encompassing the ingressing epiblast and newly formed mesoderm and (C) FGF-4-treated embryo showing a broad domain of T expression
n the posterior epiblast and the mesoderm. (D) PBS control embryos (top row) with normal Hesx1 expression in the anterior germ layers of the
mbryo (n 5 17, two experiments) and FGF-4-treated embryos (bottom row) 5 h after bead implantation showing either absent (5/15 embryos) or
small focus of Hesx1 expression (arrowhead, 10/15 embryos). (E, F) Transverse sections of (E) PBS embryo with expression in the anterior
ndoderm and (F) FGF-4-treated embryo showing absent Hesx1 expression. Bar, 100 mm. (G) Similar pattern of Otx2 expression in PBS- (top row,
n 5 17) and FGF-4-treated embryos (bottom row, n 5 17) after 5 h of culture (two experiments). (H) Hoxb1 expression in PBS (top row, n 5 9) and
FGF-4-treated embryos (bottom row, n 5 9) showing similar expression domains 5 h after treatment. Bar, 200 mm. Double arrows indicate the
rientation of the anterior–posterior (A-P) axis of histological sections.
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45FGF-4 and Anterior Developmentwas observed in the ventral neural tube and the posterior
paraxial mesoderm in some embryos (Fig 3N).
Anterior Neural Identity Is Specified but
Morphogenesis Is Suppressed in FGF-Treated
Embryos
An analysis of the expression of the neural-specific Sox2
FIG. 3. Ectopic expression of Spry2 after FGF-4 treatment. (A) Spry
n 5 9) but is strongly expressed throughout the FGF-4-treated emb
PBS control embryo viewed from the distal aspect (anterior to the t
germ layers on the posterior side. (ii, iii, and iv) Three examples
expression throughout the embryo except for the presumptive nod
Transverse sections of (C) PBS control and (D) FGF-4-treated embry
nascent mesoderm of the control embryo, but is up-regulated thro
FGF-4 specimen is due to a sectioning artifact caused by the prese
orientation of the anterior–posterior (A-P) axis. Bar, 100 mm. (E) C
onfined to the midbrain and hindbrain region and the tail bud. Ba
remains strong in the treated embryos: (F) A Class I embryo (12/70
III (17/70 embryos) showing ectopic expression of Spry2 in the he
Histological sections of FGF-4-treated embryo showing (I) Spry2 ex
expression in the neural plate and the endoderm (arrowheads) in th
in the posterior neuroectoderm, and (L–M) weak expression throu
expression in the lateral region of the trunk neural plate (M, arrowh
and the ventral neural tube tissues. Bar, 50 mm.gene revealed that all treated embryos expressed Sox2 (Figs. a
Copyright © 2000 by Academic Press. All rightA–4D) in the neural tube, indicating that neural differen-
iation has not been impaired. Several regional neural
arkers were next examined to determine whether FGF-4
reatment has any effect on the segmental delineation of
he neural tube. To determine the extent of general anterior
nd posterior neural development, Otx2 expression was
nalyzed in embryos treated with varying amounts of FGF-4
normally expressed in the primitive streak of PBS control (top row,
(bottom row, n 5 7) 3–5 h after treatment. Bar, 200 mm. (B, i) The
de) showing Spry2 expression in the primitive streak and adjacent
ctopic Spry2 activity in FGF-4-treated embryos, showing strong
d tissues in the anterior midline (arrowhead). Bar, 200 mm. (C, D)
pry2 expression is normally restricted to the posterior epiblast and
ut the epiblast following FGF-4 treatment. The shattering of the
f the heparin-coated bead in this sample. Double arrow indicates
l embryo implanted with PBS bead. Spry2 expression is normally
0 mm. (F–H) After 24 h of in vitro development, Spry2 expression
yos, three experiments), (G) Class II (41/70 embryos), and (H) Class
gion and the neural plate in the trunk region. Bar, 100 mm. (I–N)
ion in the mesendoderm (arrowhead) underneath the head folds, (J)
nk region that is deficient of paraxial mesoderm, (K) no expression
t the neuroectoderm of the head folds (L, arrowhead) but strong
and (N) expression in the medial portion of the paraxial mesoderm2 is
ryos
op si
of e
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r, 15
embr
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ghound cultured for 24 h (Figs. 4E–4H). Class I and II embryos
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46 Davidson et al.expressed Otx2 anteriorly although expression was often
reduced compared to controls. Two severely affected Class
I embryos that lacked head folds still weakly expressed
Otx2 anteriorly (Fig. 4F). In contrast to the uniform sup-
pression of Hesx1 expression observed soon after bead
placement, expression was more variable after a longer
period of culture. Expression was often reduced to a small
anterior focus in Class I and II embryos although some
Class II embryos strongly expressed Hesx1 throughout the
udimentary head folds (Figs. 5A–5D). The remaining Class
II embryos exhibited normal Hesx1 expression. A similar
eduction in Six3 expression was also observed in Class I
nd II embryos while Class III embryos showed Six3 expres-
ion similar to controls (Figs. 5E–5H). Fgf8 is expressed in
he anterior neural ridge of the forebrain later than Hesx1
nd Six3. Of all the forebrain markers assessed, Fgf8 ap-
peared to be most sensitive to the dosage effects of FGF-4.
All classes of FGF-treated embryos failed to express detect-
able levels of Fgf8 in the region corresponding to the
presumptive forebrain (Figs. 5I–5L). Hoxb1 was expressed in
the posterior regions of most treated embryos, except for
two Class I embryos with severely reduced head folds where
gene expression seemed to extend more rostrally (Figs.
4I–4L). Considered collectively, these results suggest that
the development of the anterior neural tube, specifically the
forebrain, was adversely affected in the FGF-4-treated em-
bryos.
Aberrant Development of the Midbrain–Hindbrain
Region, Primitive Streak, and Paraxial Mesoderm
In the early-somite-stage embryo, Fgf8 is expressed in the
midbrain–hindbrain boundary in addition to the anterior
neural ridge of the forebrain (Fig. 5I). In the FGF-4-treated
Class I and Class II embryos diffuse Fgf8 expression was
detected in the ventral tissues in the head folds (Figs. 5J and
5K). Histological examination revealed that Fgf8 expression
TABLE 1
The Relative Proportion in Three Different Classes of Embryos Tr
for 24 h in Vitro
FGF-4 dosage (mg/ml)a
No. of embryosWorking solution Effective
PBS control 51
0.1 0.03 45
0.2 0.07 58
1.0 0.3 138
Note. Data are collated from seven experiments.
a The dosage of FGF in the working solution is given by weight o
s the concentration of immunoreactive peptide factor quantified
b Examples of the three classes of embryos are shown in Fig. 1 an
egend.as largely confined to the mesoderm and endoderm un-
Copyright © 2000 by Academic Press. All righterlying the head fold and around the foregut portal (data
ot shown). A weak expression of Fgf8 was detected in the
presumptive midbrain to hindbrain region of the Class III
embryos (Fig. 5L). An analysis of other genes such as En1
and Wnt1 that are expressed in the midbrain revealed that
these genes were expressed in a more rostral domain in the
neural tube of the FGF-4 treated Class II embryos (En1, Figs.
6A–6D; Wnt1, Figs. 6E–6H). This anterior displacement of
expression might be related to the lack of forebrain differ-
entiation. Furthermore, the expression of Wnt3a in the
presumptive midbrain was often absent (Fig. 6J) or mark-
edly reduced in treated embryos (Figs. 6K). Krox20, which
was expressed in the third and fifth rhombomeres of the
hindbrain of the control embryos (Fig. 6M) was expressed in
some Class I (Fig. 6N) and Class II embryos. In some
embryos, expression was compressed (Fig. 6O) while in
others rhombomeric separation was lost. The Class III
embryos expressed a normal pattern of Krox20 activity (Fig.
6P). FGF-4 treatment therefore may also adversely affect the
patterning of the midbrain and the hindbrain.
In view of the expanded expression of T activity soon
after FGF-4 treatment, the expression of T, Wnt3a, and Fgf8
in the primitive streak (Figs. 5I, 6I, 7A, and 7F) was studied
in embryos cultured for 24 h to assess the impact of growth
factor treatment on the formation of the mesoderm. Con-
sistently, an expanded expression pattern of all three genes
was found in the FGF-4-treated Class I and Class II embryos
(Figs. 5J, 5K, 6J, 6K, 7B, and 7C). In the Class III-treated
embryo, the T gene was more strongly expressed (Fig. 7D)
but the expression of the Fgf8 and Wnt3a genes was
comparable to the controls (Figs. 5L and 6L). Histological
examination of the FGF-4-treated embryo showed that
there was an accumulation of cells in the primitive streak
(Figs. 3K and 7H). Furthermore, the treated embryos con-
tained an excess amount of posterior paraxial and tail bud
mesoderm (Figs. 3K and 3N) but were markedly deficient in
trunk paraxial mesoderm (Figs. 3J and 7G). Most FGF-4-
with FGF-4 by Bead Implantation and Cultured
Class Ib (%) Class IIb (%) Class IIIb (%)
0 4 96
4 34 62
9 60 31
20 68 12
ombinant protein per volume and the effective dosage is expressed
ISA.
morphological criteria for classification are described in the figureeated
f rec
by EL
d thetreated embryos developed a notochord-like axial structure
s of reproduction in any form reserved.
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47FGF-4 and Anterior Developmentwith a T-expressing midline which appeared broader and
more diffuse than controls (compare Figs. 7A with 7B–7D).
In some Class I embryos that were deficient in paraxial
mesoderm, the T gene, like the Spry2 gene, was expressed
n the endoderm underlying the neural plate (Figs. 3J and
G).
DISCUSSION
FGF-4 Activity Suppresses the Development of the
Anterior Neural Tube
The results of our study show that the disruption of the
FGF signaling process may suppress anterior neural devel-
opment in the mouse embryo, as in the embryos of Xeno-
pus, zebrafish, and chick (Isaacs et al., 1994; Griffin et al.,
995; Woo and Fraser, 1997; Henrique et al., 1997; Lom-
ardo and Slack, 1998; Holowacz and Sokol, 1999). When
he development of the neural tube is assessed by the
xpression of region-specific genes, it is revealed that FGF-4
reatment leads mainly to a defective formation of the
orebrain and the midbrain. Hesx1 expression was reduced
hortly after FGF-4 treatment. This early decrease in Hesx1
xpression may subsequently impact on the expression of
ther forebrain genes such as Six3 and Fgf8 resulting in the
bserved suppression of forebrain growth. Furthermore, the
bsent or the anterior shift in the expression of several
enes expressed in the midbrain and hindbrain regions in
GF-treated embryos could also be related to this initial
eduction of Hesx1 expression.
It has been suggested that in the chick embryo, neural
evelopment progresses through three distinct phases: com-
etence, induction, and regionalization (Streit et al., 1997).
he late gastrula mouse embryo appears to be restricted in
ts competence to respond to neural-inducing signals as
etermined by organizer transplantation assays (Bedding-
on, 1994; Tam et al., 1997) and anterior ectoderm may
ave been determined for a neural fate at this stage (Ang and
ossant, 1993). Ectopically administered FGF-4 therefore
ay alter only regionalized neural development rather than
eural induction per se. In Xenopus, FGF activity has been
hown to be sufficient to induce ectopic Krox20 expression
n animal cap explants that contain neural progenitors and
orsal mesoderm (Cox and Hemmati-Brivanlou, 1995).
FIG. 4. FGF-treated embryos showing reduced anterior neural ge
n 5 18), and (D) Class III (n 5 12) embryos all expressed Sox2
expression in presumptive forebrain and midbrain (n 5 5). (F) A m
expression. Other Class I embryos show reduced expression dom
showing normal Otx2 expression in anterior neuroectoderm. (I) PB
posterior neural tube and mesoderm. (J) A Class I embryos showin
embryos (n 5 6, not shown) show a posterior expression pattern s
embryo and in the others is confined to the lateral edges of the ope
displaying normal Hoxb1 expression in rhombomere 4 and posterior ne
Copyright © 2000 by Academic Press. All rightowever, in zebrafish, the induction of hindbrain-specific
ene activity cannot be achieved by FGF activity alone but
equires an interaction with the marginal zone of the
lastoderm (Woo and Fraser, 1997). In the chick, FGF
ctivity is sufficient to organize an ectopic midbrain–
indbrain junction and induce En1 expression (Crossley et
l., 1996; Martinez et al., 1999; Shamin et al., 1999). It must
e noted that in our study, there is no compelling evidence
hat FGF-4 activity leads to the induction of ectopic neural
issue. This could reflect a temporal divergence or varying
ensitivity of gene activation during the formation of the
idbrain–hindbrain junction (Reifers et al., 1998; Lun and
rand, 1998; Shamin et al., 1999) and a restricted compe-
ence of the late mouse gastrula to respond to exogenous
nductive signals.
Does Exogenous FGF-4 Affect Posterior
Development?
Although a positive regulatory relationship involving
FGF signaling and Brachyury transcriptional activity has
been shown in both Xenopus (Isaacs et al., 1994; Latinkic et
al., 1997; Casey et al., 1998) and zebrafish (Griffin et al.,
1995, 1998), evidence supporting a similar relationship in
the mouse embryo is less well established (see Schmidt et
al., 1997). The immediate up-regulation of T expression
soon after FGF-4 treatment indicates that T transcription is
responsive to exogenous FGF-4 in the mouse embryo.
Mutation in T results in a homozygous lethal phenotype
due to a deficiency of posterior embryonic tissue whereas
heterozygotes exhibit a milder phenotype suggesting sensi-
tivity to the levels of T-box protein activity (Smith, 1999).
In this study, the broad T expression observed soon after
FGF-4 treatment may reflect an expansion of the posterior
tissue domain of the embryo. When considered in conjunc-
tion with the known posteriorizing activity of FGF and the
ability of T-expressing tissues to suppress anterior neural
differentiation (Ang et al., 1994; Cox and Hemmati-
Brivanlou, 1995; Woo and Fraser, 1997; Koshida et al.,
1998), the effects of FGF-4 on anterior development could
be mediated by a posterior expansion of a T-dependent
effect. However, it is probably more likely that ectopic FGF
activity directly suppresses anterior neural identity as has
pression. (A) PBS control (n 5 8), (B) Class I (n 5 6), (C) Class II
ity. (E) Control PBS embryos with normal morphology and Otx2
ally affected Class I embryo with a small anterior focus of Otx2
5 14). (G) Class II (n 5 10) and (H) Class III (n 5 8) embryos
ntrol embryo with Hoxb1 expression in rhombomere 4 and in the
expanded Hoxb1domain of in the posterior tissues. Other Class I
ar to controls but expression in the rhombomere is absent in one
ural plate. (K) Class II (n 5 13) and (L) Class III (n 5 12) embryosne ex
activ
axim
ain (n
S co
g an
imil
n neural tube. Bar, 150 mm.
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i48 Davidson et al.FIG. 5. Forebrain development is suppressed by FGF-4 treatment. (A–D) Hesx1 expression. (A) Control embryo shows normal expression
n the forebrain tissues (n 5 9). (B) Class I embryos (n 5 4) displayed a reduced focus of Hesx1 expression. (C) Some Class II embryos (n 5
6) had a similar reduction in Hesx1 activity but 3 embryos (as shown in the figure) expressed Hesx1 strongly in the entire head fold. The
remaining Class II (n 5 7) and (D) Class III embryos (n 5 2) show Hesx1 activity similar to the controls. (E–H) Six3 expression. (E) Control
embryo. (F) Class I embryo shows a markedly reduced Six3 expression, while (G, H) the Class II and all Class III embryos show a normal
expression pattern. (I–L) Fgf8 expression. (I) The expression of Fgf8 in the anterior neural ridge of the forebrain (arrow), the mid- and
hindbrain junction (arrowhead) and the primitive streak of control embryo (n 5 9). (J, K, L) Expression of Fgf8 in the presumptive forebrain
region (arrows) is absent in the 26 of 27 treated embryos (Class I n 5 3, Class II n 5 14, Class III n 5 10). In (J) the Class I embryo, Fgf8,
is expressed in the mesendoderm of the foregut and not in the neuroectoderm. An expanded posterior expression domain is also apparent
in the tail bud/primitive streak region of Class I and II embryos. Bar, 150 mm.
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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49FGF-4 and Anterior DevelopmentFIG. 6. Midbrain and hindbrain gene activity is disrupted by FGF-4 treatment. (A) Normal expression of En1 in the caudal midbrain and
rostral hindbrain neuroectoderm. The anterior border of the expression domain (arrowhead) does not extend into the forebrain. (B) A Class
I embryo which showed weak En1 expression although four others failed to initiate any expression. (C) Class II embryos (n 5 16) expressed
En1 more rostrally in the neural tube (arrowhead), consistent with the loss of forebrain tissues. (D) Normal expression in Class III embryos
(n 5 8). (E–H) Wnt1 expression. (E) Normal expression of Wnt1 marks the caudal midbrain region and dorsal neural tube in the control
embryo. (F) Anterior expression of Wnt1 was present in most Class I embryos (8/10 embryos). In 3 embryos, expression extended caudally
nto the lateral regions of the open neural plate (not shown). (G) A Class II embryo (n 5 17) expressing Wnt1 more rostrally in the small
ead folds (arrowhead) (n 5 8). (H) Class III embryos (n 5 9) showing normal expression. (I–L) Wnt3a expression. (I) Expression in the
orsal/lateral midbrain region, dorsal neural tube, and primitive streak/tail bud of the control embryo. (J) Class I embryos (n 5 6) showing
o Wnt3a expression in the anterior neuroectoderm. (K) Class II embryos (n 5 15) which developed rudimentary head folds had detectable
xpression (arrowhead) along the lateral regions of the open neural plate. (L) A Class III embryo showing normal Wnt3a expression. (M)
ormation of the hindbrain rhombomeres 3 and 5 was revealed by Krox20 expression. (N) Normal Krox20 expression was observed in only
ne Class I embryo (shown) while in others expression was reduced to one band or absent. (O) Only one stripe of Krox20 expression is
bserved in this Class II embryo (arrowhead) while (P) the Class III embryo displays normal expression. Bar, 150 mm.
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
l
i
i
e
s
F
d
w
s
t
v
X
s
C
d
a
m
c
s
r
a
c
i
t
c
o
t
r
m
d
w
t
d
t
1
p
s
d
s
o
o
m
i
o
o
e
m
s
a
F
f
t
b
t
s
e
A
50 Davidson et al.been shown in FGF-treated Keller explants (Holowacz and
Sokol, 1999).
Effects of FGF-4 on Embryonic Development
Is Mediated by the Negative Regulation
of FGF Signaling
Interestingly, viral overexpression of Sprouty in chick
imb buds causes a phenotype consistent with a reduction
n FGF signaling. However, the data also raise the possibil-
ty that in some cases Sprouty gene overexpression may
nhance FGFR signaling (Minowada et al., 1999). In this
tudy, the widespread ectopic expression of Spry2 soon after
GF-4 treatment in the tissues that are also known to
isplay FGFR1 activity implies that FGFR signaling is
idely activated in the embryo. The activation of FGFR
ignaling is apparently also not restricted to the tissues in
he vicinity of the exogenous source of FGF-4. This obser-
ation is in marked contrast to the findings in chick and
enopus embryos where a more local effect of FGF has been
hown after bead or cell implantation (Storey et al., 1998;
hristen and Slack, 1999). It is important to consider the
ifferences between these experimental models that might
ccount for the more widespread effect of FGF-4 in the
ouse gastrula. The mouse gastrula is much smaller by
omparison with the chick and Xenopus gastrula, and as
uch, a soluble growth factor placed at a specific site may
each more embryonic tissues. The presence of an enclosed
mniotic cavity may also facilitate the trapping and indis-
riminate transfer of the growth factor released from the
mplanted bead to other regions of the embryo.
The initial activation of a negative FGF signaling regula-
or and its subsequent ectopic expression therefore compli-
ate the interpretation of experiments of this kind. Is the
bserved phenotype a result of activation or inactivation of
he signaling pathway? Although the variable phenotypes
eported for FGFR1 null mutants and chimeras suggest
ultiple requirements for FGFR1 signaling during early
evelopment, there are several parallels that can be drawn
ith the phenotypes observed in this study. Like FGF-4-
reated embryos, FGFR1 null mutants develop with small
isorganized head folds and a disruption in the formation of
he trunk mesoderm (Yamaguchi et al., 1994; Deng et al.,
994). However, in contrast, Fgfr12/2 cells in the chimera
fail to differentiate into mesoderm and adopt a neural fate,
a phenotype not observed after FGF-4 treatment (Ciruna et
al., 1997; Deng et al., 1997). In the most severely affected
Class I embryos a dramatic decrease in the amount of
paraxial mesoderm and an accumulation of cells in the
FIG. 7. (A–H) Notochord differentiation following FGF-4 treatmen
showing the expression of T in the in the notochord (A, E), the pri
Whole mount and (G, H) histological sections of Class I embryos sho
in the (G) endoderm underlying the open neural plate and (H) th
expression in axial mesodermal tissues, which are often less compact t
Copyright © 2000 by Academic Press. All rightosterior mesoderm and the primitive streak were ob-
erved. Less severely affected Class II embryos showed a
isruption in somitogenesis in the trunk suggesting that the
egmentation process had stalled. However, the formation
f the notochord appeared largely unaffected in the majority
f embryos although instances of broader T-expressing
idline tissues were observed in some Class I embryos. The
nitial expansion of T expression could also have impacted
n the differentiation of the ingressing mesoderm, a region
f high endogenous FGF activity. As there appears to be
xtensive ectopic Spry2 expression following FGF treat-
ent it is likely that endogenous FGFR signaling has been
uppressed or blocked (Minowada et al., 1999). This may
ffect the normal morphogenetic signals provided by the
GF signaling pathway that are required for mesoderm
ormation. The widespread expression of a negative regula-
or (Spry2) suggests that these morphogenetic effects may
e a consequence of a suppressive activity counteracting
he overactivation of the FGFR signaling pathway by exces-
ive FGF.
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